Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.

Cannabinoids are specific chemical compounds found in cannabis, such as tetrahydrocannabinol (THC) and cannabidiol (CBD). Research is increasingly su ...

In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Insmed, with a price target of $130.00. The company’s shares opened today at $109.83. Take advantage of ...

The postoperative pain management market is witnessing steady growth, driven by the rising number of surgical procedures globally and increasing awar ...

The risk for several adverse health outcomes, including PTSD, traumatic brain injury and anxiety, was heightened among active ...

Q2 2025 Earnings Call Transcript August 4, 2025 Axsome Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.92 ...

Axsome Therapeutics Inc (AXSM) reports a 72% year-over-year revenue increase, driven by strong product sales and strategic ...

McEwen Inc. (NYSE: MUX) (TSX: MUX) (“McEwen”, "MUX" or the "Company”) invites you to join our conference call following the release of our ...

Axsome (AXSM) delivered earnings and revenue surprises of +8.00% and +7.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

TRUNNANO, a leading global supplier of high-performance nanomaterials and advanced chemical materials, is proud to announce the launch of its latest product: ...

(AXSM) on Monday reported a loss of $48 million in its second quarter. On a per-share basis, the New York-based company said it had a loss ...